These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19348339)

  • 1. Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins.
    Van de Ven H; Vermeersch M; Shunmugaperumal T; Vandervoort J; Maes L; Ludwig A
    Pharmazie; 2009 Mar; 64(3):172-6. PubMed ID: 19348339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR; Hua SC; Yang YL; Fang JY
    Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
    Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
    Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery.
    Yu W; Liu C; Ye J; Zou W; Zhang N; Xu W
    Nanotechnology; 2009 May; 20(21):215102. PubMed ID: 19423923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
    Pedersen N; Hansen S; Heydenreich AV; Kristensen HG; Poulsen HS
    Eur J Pharm Biopharm; 2006 Feb; 62(2):155-62. PubMed ID: 16290122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J; Pang X; Yu K; Liu L; Zhou J
    Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production.
    Olbrich C; Schöler N; Tabatt K; Kayser O; Müller RH
    J Pharm Pharmacol; 2004 Jul; 56(7):883-91. PubMed ID: 15233867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.
    Schubert MA; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):77-86. PubMed ID: 16011893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.
    Souto EB; Müller RH
    Pharmazie; 2007 Jul; 62(7):505-9. PubMed ID: 17718190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
    Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
    J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yak interferon-alpha loaded solid lipid nanoparticles for controlled release.
    Li S; Zhao B; Wang F; Wang M; Xie S; Wang S; Han C; Zhu L; Zhou W
    Res Vet Sci; 2010 Feb; 88(1):148-53. PubMed ID: 19647842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil.
    Sharma P; Ganta S; Denny WA; Garg S
    Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.
    Serpe L; Catalano MG; Cavalli R; Ugazio E; Bosco O; Canaparo R; Muntoni E; Frairia R; Gasco MR; Eandi M; Zara GP
    Eur J Pharm Biopharm; 2004 Nov; 58(3):673-80. PubMed ID: 15451544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity.
    Kuntsche J; Koch MH; Fahr A; Bunjes H
    Eur J Pharm Sci; 2009 Oct; 38(3):238-48. PubMed ID: 19664705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.